Clinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung Cancer
Clinical trial NCT04487093 · UNKNOWN
Trial details
- NCT number
- NCT04487093
- Sponsor
- First Hospital of Shijiazhuang City
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-17
- Primary completion
- 2022-05-17
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.